Abstract
Aims To evaluate the immunogenicity of LY2963016 insulin glargine (LY IGlar) versus originator insulin glargine (IGlar [Lantus (R)]) in Chinese patien......
小提示:本篇文献需要登录阅读全文,点击跳转登录